Literature DB >> 6131076

Taxol resistant mutants of Chinese hamster ovary cells: genetic biochemical, and cross-resistance studies.

R S Gupta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131076     DOI: 10.1002/jcp.1041140122

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


× No keyword cloud information.
  7 in total

Review 1.  New microtubular agents in pediatric oncology.

Authors:  N L Seibel; G H Reaman
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Griseofulvin resistance mutation of Chinese hamster ovary cells that affects the apparent molecular weight of a congruent to 200,000-dalton protein.

Authors:  R S Gupta
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

Review 3.  Risks and benefits of taxanes in breast and ovarian cancer.

Authors:  L B Michaud; V Valero; G Hortobagyi
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

4.  Formycin B-resistant mutants of Chinese hamster ovary cells: novel genetic and biochemical phenotype affecting adenosine kinase.

Authors:  K D Mehta; R S Gupta
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

Review 5.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

6.  Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells.

Authors:  D Boscoboinik; R S Gupta; R M Epand
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

7.  Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.

Authors:  J van Meerbeeck; C Debruyne; N van Zandwijk; P E Postmus; M C Pennucci; F van Breukelen; D Galdermans; H Groen; P Pinson; M van Glabbeke; E van Marck; G Giaccone
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.